Trump’s first-term rule—“Most Favored Nation”—was focused on lowering the cost of Medicare payments on certain drugs, but the ...

Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.

Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Local pharma stocks were rocky on Friday after President Donald Trump directed major drugmakers to reduce the cost of their ...

The Food and Drug Administration (FDA) issuing marketing granted orders (MGOs) for Juul e-cigarettes is facing opposition ...

A new longitudinal study involving more than 240,000 individuals in the United Kingdom suggests that people who used both ...

Research and development (R&D) expenses were $49.5 million for the second quarter of 2025, compared to $49.9 million for the comparable period in 2024. The decrease was primarily related to the ...

Skittles, Nestlé and Hershey pledge to remove artificial colors, but experts argue these changes are merely cosmetic, urging ...

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

In the fourth part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & distribution services, explains how with years of trial and error behind them, ...

With President Trump's sweeping tariffs set to come into full effect later this week, focus has centered on last-minute, ...